Dr. M S Belliappa
DesignationHead of Department (HOD)
SpecialtyRadiation Oncologist
Experience 30 years of experience
HospitalAster CMI Hospital
Languages SpokenEnglish, Hindi, Kannada, Tamil
About Dr. M S Belliappa
- Dr. M S Belliappa is a senior and highly respected Radiation Oncologist with over three decades of experience in clinical oncology.
- He has extensive expertise in advanced radiation therapy techniques, including IGRT, IMRT, VMAT, SRS, and SBRT.
- He has a special clinical interest in the treatment of breast cancers, head and neck cancers, and gynaecological cancers.
- He is widely recognised for his contribution to high-precision radiotherapy and comprehensive cancer care.
Specializations & Conditions Treated
Intensity-Modulated Radiotherapy (IMRT)
Vaginal Cancer Treatment
Ovarian Cancer Treatment
Breast Cancer Treatment
Prostate Cancer Treatment
Education
MBBS
DMRT
MD (Radiation Therapy)
DNB (Radiation Therapy)
Work Experience of Dr. M S Belliappa
He is currently serving as HOD and Lead Consultant – Radiation Oncology at Aster CMI Hospital and Aster Whitefield Hospital, Bangalore.
He has received advanced training in brachytherapy for gynaecological and prostate cancers at Long Beach Memorial Medical Cancer Hospital, Los Angeles.
He has completed fellowships in high-precision radiotherapy techniques from California Cancer Hospital, Fresno, USA, and Heidelberg University, Germany.
He holds certified CyberKnife training from Stanford University, California, and Mount Sinai Hospital, Philadelphia.
He has played an active leadership role in oncology organisations at both state and city levels.
Awards & Recognition
He served as President of the Association of Radiation Oncologists of India (AROI), Karnataka Chapter (2016–2017).
He served as Secretary of the Association of Radiation Oncologists – Karnataka Chapter.
He served as Secretary of the Bengaluru Oncology Group.
Publications
He has authored over 40 publications in national and international journals, books, and book chapters in diverse areas of oncology.
He has served as a principal investigator and sub-investigator for more than 30 clinical trials across multiple cancer types.
He has presented and published research papers at more than 25 national and international scientific conferences.
Our website uses cookies. By clicking on accept you give your consent to the use of cookies as per our Privacy Policy.